Endocrine Therapy for Early Breast Cancer: Updated Review.

about

Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling

P2860

Q58734220-A6575A60-EE32-4F3D-866D-F318E8BF64C8 Q58767821-F1C78F2B-80E9-45EE-8496-65720544E54B Q58803502-5DEB49B0-EB43-4C79-A2FD-2A76E80365C6

P2860

Endocrine Therapy for Early Breast Cancer: Updated Review.

Item

http://www.wikidata.org/entity/Q47161589

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Endocrine Therapy for Early Breast Cancer: Updated Review.

@en

Endocrine Therapy for Early Breast Cancer: Updated Review.

@nl

type

Item

label

Endocrine Therapy for Early Breast Cancer: Updated Review.

@en

Endocrine Therapy for Early Breast Cancer: Updated Review.

@nl

prefLabel

Endocrine Therapy for Early Breast Cancer: Updated Review.

@en

Endocrine Therapy for Early Breast Cancer: Updated Review.

@nl

P1476

Endocrine Therapy for Early Breast Cancer: Updated Review.

@en

P2093

Alexander Tremont

http://www.w3.org/2001/XMLSchema#string

John T Cole

http://www.w3.org/2001/XMLSchema#string

Jonathan Lu

http://www.w3.org/2001/XMLSchema#string

P2860

NSABP breast cancer clinical trials: recent results and future directions

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Cancer statistics, 2016

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

P304

405-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29230126

http://www.w3.org/2001/XMLSchema#string

P932

5718454

http://www.w3.org/2001/XMLSchema#string

Endocrine Therapy for Early Breast Cancer: Updated Review.

about

P2860

P2860

Endocrine Therapy for Early Breast Cancer: Updated Review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932